[DOI] [PubMed] [Google Scholar] 39.Vanderauwera S., Suzuki N., Miller G., van de Cotte B., Morsa S., Ravanat J.L., Hegie A., Triantaphylids C., Shulaev V., van Montagu M.C., et al
The GLP-1 receptor agonist Mounjaro (Tirzepatide) is now commonly used for weight loss, typically in those with type 2 diabetes
Fixing hangovers is our specialty, but were here for morewhether you need post-hike rehydration, jet lag relief, or to conquer a nagging cold
By amplifying your own GLP-1 signaling, semaglutide does three things at once: it reduces appetite and food cravings, slows how quickly your stomach empties so you feel satisfied longer, and improves how your body handles blood sugar
I'll keep you posted, but encourage others to try this product